CRNX Stock Analysis: Buy, Sell, or Hold?
CRNX - Crinetics Pharmaceuticals, Inc.
$37.48
0.00 (0.00%)
▲
5d:
-13.82%
30d:
-5.76%
90d:
-14.97%
WAIT
LOW Confidence
Analysis Updated: May 13, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Smart Money Accumulation
CRNX is down 10.1% this week, but smart money is accumulating calls. Top strike: $40 2026-06-18 with 183 OI. Call ratio: 75% View Scanner →
Strength: 7.6/10
Get Alerted When CRNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CRNX is down 13.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CRNX is down 13.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CRNX is currently trading at $37.48, which is considered oversold relative to its 30-day fair value range of $37.79 to $40.72.
Technical Outlook: Technically, CRNX is in a strong downtrend. Immediate support is located at $35.59, while resistance sits at $43.62.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $83.43 (+122.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRNX is in a strong downtrend. Immediate support is located at $35.59, while resistance sits at $43.62.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $83.43 (+122.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$37.79 -
$40.72
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 122.6% below Wall St target ($83.43)
- WARNING: Recommendation downgraded due to -13.8% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$37.79 -
$40.72
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$35.60
Resistance Level
$43.62
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.70
Wall Street Target
$83.43
(+122.6%)
Revenue Growth (YoY)
2873.4%
Share & Embed Analysis
Last updated: May 14, 2026 11:45 AM ET
Data refreshes hourly during market hours. Next update: 12:45 PM
Data refreshes hourly during market hours. Next update: 12:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRNX showing a specific setup today?
Insider Activity (6 Months)
1
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Jeff E Knight
SELL
85163 shares
2026-04-08
Jeff E Knight
SELL
9911 shares
2026-03-16
Richard Scott Struthers
SELL
21981 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 54 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 55 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$73 | 54 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$297 | 59 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
